King's College London

Research portal

Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities

Research output: Contribution to journalArticle

Jose de Leon, Maria J. Arranz, Gualberto Ruano

Original languageEnglish
Pages (from-to)599 - 617
Number of pages19
JournalClinics in Laboratory Medicine
Issue number4
Publication statusPublished - Dec 2008

King's Authors

Research Groups

  • King's College London


This article focuses on the first generation of pharmacogenetic tests that are potentially useful in psychiatry All pharmacogenetic tests currently on the market, or soon to be marketed in psychiatry, for which some information has been published in peer-reviewed journal articles (or abstracts), were selected. Five pharmacogenetic tests are reviewed in detail: the Roche AmpliChip CYP450 Test, the Luminex Tag-It Mutation Detection Kit, the LGC clozapine response test, the PGxPredict: Clozapine test, and the Genomas PhyzioType system. After reviewing these tests, three practical aspects of implementing pharmacogenetic testing in psychiatric clinical practice are briefly reviewed: (1) the evaluation of these tests in clinical practice, (2) cost-effectiveness, and (3) regulatory oversight. Finally, the future of these and other pharmacogenetic tests in psychiatry is discussed.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454